Hero image with Pittsburgh background pittplusme.org/study/2023

STUDY BASICS

Are you pregnant and planning to deliver at UPMC Magee-Womens Hospital? Have you already received, or are you scheduled to receive, a COVID-19 vaccination? You may be able to participate in a study to better understand how vaccination in pregnancy could benefit mothers and their infants. Participation in this study will last up to 12 months after delivery. Compensation is provided.


IRB:
  STUDY21040091A - Observational, Prospective Cohort Study of the Immunogenicity and Safety of SARSCoV- 2 Vaccines Administered during Pregnancy or Postpartum and Evaluation of Antibody Transfer and Durability in Infants (DMID 21-0004)



Age Range
AGE:   18 and up

 
Gender List
SEX ASSIGNED AT BIRTH:   Female

Duration DURATION:  Up to 12 months after delivery
VISITS:  Up to 6

Location LOCATION: 
UPMC Magee-Womens Hospital - Oakland
Compensation COMPENSATION: 

At least $450 for completing all visits & parking pass

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/2023
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Katherine Bunge

Katherine Bunge, MD, MPH, is an Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences at Magee-Womens Hospital of UPMC. Dr. Bunge's research interests include investigating the safety of vaginal microbicide products, expanding contraceptive options in HIV prevention trials, and developing alternative microbicide formulations. Dr. Bunge earned her medical and masters degrees from the Johns Hopkins School of Medicine, completed her residency at Northwestern Memorial Hospital, and performed her fellowship at Magee-Womens Hospital of UPMC.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet